Le Lézard

Aion Medicines Presents Data at ObesityWeek Demonstrating Ultra-long-acting Pharmacokinetics and Pharmacodynamic Effects of AM-710, a Potential Best-in-class GLP-1 Receptor ...

Aion Medicines, a subsidiary of Exavir Therapeutics, announced the presentation of preclinical data for AM-710, the company's ultra-long-acting small molecule GLP1R agonist, at the ObesityWeek ...

RO TO PRESENT EIGHT RESEARCH ABSTRACTS AT OBESITYWEEK 2025

Ro, the leading direct-to-patient healthcare company, was selected to present eight new research abstracts at ObesityWeek ...

Rivus Pharmaceuticals Presents Preclinical Data for Controlled Metabolic Accelerator (CMA) Pipeline Showing Fat-Selective, Muscle-Preserving Weigh…

First data from Rivus’ preclinical CMA pipeline showing potential as monotherapy and in combination with ...
The Chronicle of Higher Education

AI Has Joined the Faculty

By the time generative AI came on the scene, he had read enough books on teaching to have a “pretty-good sense” of how he was supposed to design an effective course. What he didn’t have was help.
Le Lézard

Accordion Survey Reveals 72% of Sponsors Say CFOs Fall Short on Exit Readiness; Misalignment Risks Up to 3 Turns of Valuation

Accordion, an AI and data-powered financial consulting firm focused on private equity, today released Exit Readiness in Private Equity, the latest report in its ongoing series The State of the PE ...